B. Riley Securities Initiates Coverage On WAVE Life Sciences with Buy Rating, Announces Price Target of $11
Portfolio Pulse from Benzinga Newsdesk
B. Riley Securities has initiated coverage on WAVE Life Sciences with a Buy rating and set a price target of $11.
September 19, 2024 | 11:28 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B. Riley Securities has initiated coverage on WAVE Life Sciences with a Buy rating and a price target of $11, indicating a positive outlook.
The initiation of coverage with a Buy rating and a specific price target of $11 by B. Riley Securities suggests a positive sentiment towards WAVE Life Sciences. This is likely to attract investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100